Search

everythinglearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

A woman with undifferentiated connective tissue disease was diagnosed with renal amyloidosis and carpal tunnel syndrome.

The new gel formulation for Acitretin improves topical delivery and reduces oral toxicity.

The new method makes finasteride production cheaper and safer for industry.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

A woman developed a hair disorder after a bone marrow transplant, which improved with treatment.

Pityriasis amiantacea is likely linked to eczema-related skin changes.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Zinc supplements improved the girl's skin and hair condition.

New compounds show promise as nonsteroidal treatments for hair loss.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Two brothers from Bangladesh were diagnosed with X-linked adrenoleukodystrophy, showing neurological and adrenal symptoms.

A new treatment for hair loss shows promise with fewer side effects.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

A non-toxic formula using polycarboxylic acids strengthens and improves hair.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Alopecia areata incognita causes sudden hair thinning, responds well to steroids, and is more common in those with genetic hair loss conditions.

Transglutaminases work through a ping-pong mechanism, and human plasma and platelet transglutaminases have similar catalytic subunits.

Ritlecitinib is safe and may effectively treat alopecia areata.

Apremilast did not work for treating severe alopecia areata.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.